An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial

A Tran-Duy, M Ghiti Moghadam, M Voshaar, HE Vonkeman, A Boonen, P Clarke, G McColl, PM ten Klooster, TR Zijlstra, WF Lems, N Riyazi, EN Griep, Mieke Hazes, R Landewe, HJ Bernelot Moens, P van Riel, M Laar, TL Jansen

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1557-1564
Number of pages8
Issue number10
Publication statusPublished - 2018

Cite this